Prospects of animal models and their application in studies on adaptive immunity to SARS-CoV-2

被引:4
|
作者
Wei, Xiaohui [1 ]
Rong, Na
Liu, Jiangning [1 ]
机构
[1] Inst Lab Anim Sci, Chinese Acad Med Sci, Natl Hlth Commiss Key Lab Human Dis Comparat Med, Beijing Key Lab Anim Models Emerging & Remerging I, Beijing, Peoples R China
来源
FRONTIERS IN IMMUNOLOGY | 2022年 / 13卷
基金
中国国家自然科学基金;
关键词
SARS-CoV-2; animal model; adaptive immunity; cross-immune response; tissue-resident immune response; immune memory; CORONAVIRUS DISEASE 2019; T-CELL RESPONSES; CLINICAL CHARACTERISTICS; NEUTRALIZING ANTIBODIES; EFFECTOR FUNCTIONS; INFECTION; COVID-19; PROTECTS; MERS; SARS;
D O I
10.3389/fimmu.2022.993754
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The adaptive immune response induced by SARS-CoV-2 plays a key role in the antiviral process and can protect the body from the threat of infection for a certain period of time. However, owing to the limitations of clinical studies, the antiviral mechanisms, protective thresholds, and persistence of the immune memory of adaptive immune responses remain unclear. This review summarizes existing research models for SARS-CoV-2 and elaborates on the advantages of animal models in simulating the clinical symptoms of COVID-19 in humans. In addition, we systematically summarize the research progress on the SARS-CoV-2 adaptive immune response and the remaining key issues, as well as the application and prospects of animal models in this field. This paper provides direction for in-depth analysis of the anti-SARS-CoV-2 mechanism of the adaptive immune response and lays the foundation for the development and application of vaccines and drugs.
引用
收藏
页数:18
相关论文
共 50 条
  • [21] Transmissibility and pathogenicity of SARS-CoV-2 variants in animal models
    Kim, Young-Il
    Casel, Mark Anthony B.
    Choi, Young Ki
    JOURNAL OF MICROBIOLOGY, 2022, 60 (03) : 255 - 267
  • [22] SARS-CoV-2 Variants, Vaccines, and Host Immunity
    Mistry, Priyal
    Barmania, Fatima
    Mellet, Juanita
    Peta, Kimberly
    Strydom, Adele
    Viljoen, Ignatius M.
    James, William
    Gordon, Siamon
    Pepper, Michael S.
    FRONTIERS IN IMMUNOLOGY, 2022, 12
  • [23] The Mechanisms and Animal Models of SARS-CoV-2 Infection
    Jia, Wenrui
    Wang, Juan
    Sun, Bao
    Zhou, Jiecan
    Shi, Yamin
    Zhou, Zheng
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2021, 9
  • [24] Animal models for SARS-CoV-2 infection and pathology
    Bi, Zhenfei
    Hong, Weiqi
    Yang, Jingyun
    Lu, Shuaiyao
    Peng, Xiaozhong
    MEDCOMM, 2021, 2 (04): : 548 - 568
  • [25] Structural and functional modelling of SARS-CoV-2 entry in animal models
    Brooke, Greg N.
    Prischi, Filippo
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [26] Adaptive immunity to SARS-CoV-2 and COVID-19
    Sette, Alessandro
    Crotty, Shane
    CELL, 2021, 184 (04) : 861 - 880
  • [27] Prospects for SARS-CoV-2 diagnostics, therapeutics and vaccines in Africa
    Margolin, Emmanuel
    Burgers, Wendy A.
    Sturrock, Edward D.
    Mendelson, Marc
    Chapman, Rosamund
    Douglass, Nicola
    Williamson, Anna-Lise
    Rybicki, Edward P.
    NATURE REVIEWS MICROBIOLOGY, 2020, 18 (12) : 690 - 704
  • [28] T cell immunity to SARS-CoV-2
    Niessl, Julia
    Sekine, Takuya
    Buggert, Marcus
    SEMINARS IN IMMUNOLOGY, 2021, 55
  • [29] Durability of Immunity to SARS-CoV-2 and Other Respiratory Viruses
    Siggins, Matthew K.
    Thwaites, Ryan S.
    Openshaw, Peter J. M.
    TRENDS IN MICROBIOLOGY, 2021, 29 (07) : 648 - 662
  • [30] Animal models of SARS-CoV-2 and COVID-19 for the development of prophylactic and therapeutic interventions
    Renn, Marcel
    Bartok, Eva
    Zillinger, Thomas
    Hartmann, Gunther
    Behrendt, Rayk
    PHARMACOLOGY & THERAPEUTICS, 2021, 228